ITMCTR2000003033Not yet recruitingPhase 1
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 60 (—)
- Sex
- All
Inclusion Criteria
- •1. Aged 18 to 60 years old;
- •2. Inpatients who meet the diagnostic criteria for mild, general and neonatal pneumonia in western medicine, and early and recovery stages of traditional Chinese medicine;
- •3. Understand and agree to participate in this study and sign the informed consent.
Exclusion Criteria
- •1. Patients with other serious diseases such as lung diseases, cardiovascular and cerebrovascular diseases, hematopoietic diseases, autoimmune diseases, digestive system, or mental illness;
- •2. Pregnant or lactating women;
- •3. Participate in other forms of exercise during the trial
Investigators
Similar Trials
Recruiting
Phase 3
A randomized controlled trial into the efficacy of neurofeedback for treatment of major depressive disorderdepressionmajor depressive disorder10027946NL-OMON41680Medisch Universitair Ziekenhuis Maastricht50
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
Completed
Phase 3
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000011007Department of breast and endocrine surgery, Meiwa Hospital35
Completed
Not Applicable
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomniaInsomniaJPRN-UMIN000023999europsychiatric Research Institute40